Plumbline Life Sciences, Inc. (XKON:A222670) announced a private placement of 100,000 preferred stock at KRW 11,000 per share for gross proceeds of KRW 1,100,000,000 on November 23, 2020. Each share has a face value of KRW 500 and issued at premium. The transaction included participation Dadam 4th Industry Social Impact Fund, a fund managed by DADAM Investment Corp. The preferred shares will be redeemable and will be convertible from December 01, 2020 to November 30, 2030. Each preferred share will be convertible into one common share of the company. The transaction has been approved by board of directors. The preferred shares will be issued through third party allotment method. The payment date is November 30, 2020.